StockData
Aldeyra Therapeutics, Inc. logo

Aldeyra Therapeutics, Inc. (ALDX) stock

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.69+0.02 (+3.63%)

Close on Nov 17, 2026Market cap $41.86MP/E –Yield –

Aldeyra Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Aldeyra Therapeutics's pe ratio was 10.3× on Jan 30, 2015.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jan 30, 201510.3×+4.1
2014Dec 31, 20146.1×–

More Aldeyra Therapeutics figures

See a number that looks wrong?